Bilimsel çalışmalar

Uzm. Dr. İlker Nihat Ökten

114 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

    Medicina, 2026

    DOI 10.3390/medicina62050984 PMID 42195237 Açık erişimli tam metinKaynak: OpenAlex

  2. Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3–6 Month Relapse Window

    Current Oncology, 2026

    DOI 10.3390/curroncol33080472 PMID 42645377 Açık erişimli tam metinKaynak: OpenAlex

  3. Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye

    Current Oncology, 2026

    DOI 10.3390/curroncol33030155 PMID 41892183 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  4. Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

    Clinics and Practice, 2026

    DOI 10.3390/clinpract16090158 PMID 42783081 Açık erişimli tam metinKaynak: OpenAlex

  5. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Açık erişimli tam metinKaynak: OpenAlex

  6. Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020467 PMID 41598406 Açık erişimli tam metinKaynak: ORCID

  7. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16667-y PMID 42693417 Açık erişimli tam metinKaynak: OpenAlex

  8. Baseline [¹⁸F]FDG PET/CT metrics and systemic inflammatory indices in relation to overall survival in a real-world breast cancer cohort

    Clinical and Translational Imaging, 2026

    DOI 10.1007/s40336-026-00767-7 Kaynak: OpenAlex

  9. The Effect of MCV on Prognosis in Patients with Gastric Cancer and its Relationship with C-ERBB2 Positivity

    Eurasian Journal of Medical Advances, 2026

    DOI 10.14744/ejma.260309 Açık erişimli tam metinKaynak: OpenAlex

  10. Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study

    Lung Cancer, 2026

    DOI 10.1016/j.lungcan.2026.109590 PMID 42664544 Açık erişimli tam metinKaynak: ORCID

  11. Risk Tier, Variant Certainty, and Real-World Care Patterns in Breast Cancer Patients with Germline Alterations in Breast Cancer Susceptibility Genes

    Cancers, 2026

    DOI 10.3390/cancers18101499 PMID 42192861 Açık erişimli tam metinKaynak: ORCID

  12. Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15721-z PMID 41688965 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  13. Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103936 PMID 42194896 Açık erişimli tam metinKaynak: OpenAlex

  14. Integrating PET/CT-derived heterogeneity indices and composite risk scores improves prognostic stratification in breast cancer

    European journal of nuclear medicine and molecular imaging, 2026

    DOI 10.1007/s00259-025-07622-3 PMID 41191096 2 atıf (Europe PMC) Kaynak: Europe PMC

  15. Hemoglobin-to-Red Cell Distribution Width Ratio Independently Predicts Survival in Non-Metastatic Gastric Cancer: A Retrospective Cohort Study

    Medicina, 2026

    DOI 10.3390/medicina62091797 PMID 42796403 Açık erişimli tam metinKaynak: ORCID

  16. Case Report: Immune checkpoint inhibitor-triggered anti-Ma2 paraneoplastic encephalitis in sarcomatoid pleural mesothelioma: a fatal case

    Frontiers in Oncology, 2026

    DOI 10.3389/fonc.2026.1739494 PMID 41878538 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  17. Prognostic Value of Nutritional Status and Early Tumor Marker Dynamics in Metastatic Gastric Cancer

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.269284 Kaynak: ORCID

  18. Recurrent Detection of TERT Promoter Mutation in HPV-independent Cervical Squamous Cell Carcinoma: A Letter Regarding Horn et al

    International Journal of Gynecological Pathology, 2026

    DOI 10.1097/pgp.0000000000001130 PMID 40758763 Kaynak: ORCID

  19. PS4-05-14: Integrated NGS-Based Tissue and Plasma Profiling to Advance Precision Oncology in Breast Cancer

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-05-14 Kaynak: OpenAlex

  20. The Prognostic Value of a Composite Score in Predicting Mortality Among Metastatic Castration-resistant Prostate Cancer Patients Treated with Enzalutamide

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-2-3 Açık erişimli tam metinKaynak: OpenAlex

  21. Prognostic Value of CA 19-9 Elimination Rate for Mortality in Metastatic Pancreatic Cancer

    Annals of Medical Research, 2026

    DOI 10.5455/annalsmedres.2026.01.018 Açık erişimli tam metinKaynak: OpenAlex

  22. A lipoleiomyosarcoma of the ligamentum rotundum mimicking dedifferentiated liposarcoma at recurrence

    Human Pathology, 2026

    DOI 10.1016/j.humpath.2026.106111 PMID 41951056 Kaynak: OpenAlex

  23. Real-world clinical responses to selpercatinib in RET M918T-mutant medullary thyroid carcinoma

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04881-w PMID 41954849 Açık erişimli tam metinKaynak: OpenAlex

  24. 430P Efficacy of CDK4/6 inhibitors in BRCA-mutated HR+/HER2- metastatic breast cancer: Turkish Oncology Group (TOG) study

    ESMO Open, 2026

    DOI 10.1016/j.esmoop.2026.107453 Açık erişimli tam metinKaynak: OpenAlex

  25. Baseline FDG PET/CT–Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer

    Nuklearmedizin - NuclearMedicine, 2026

    DOI 10.1055/a-2825-4883 PMID 42167287 Kaynak: OpenAlex

  26. Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e15188 Kaynak: OpenAlex

  27. Renal Pelvis Squamous Cell Carcinoma Arising in the Setting of Long-Standing Nephrolithiasis: Clinicopathologic and Molecular Insights

    International Journal of Surgical Pathology, 2026

    DOI 10.1177/10668969261449478 PMID 42231820 Kaynak: OpenAlex

  28. Nodular Fasciitis of the Vulva: Clinicopathologic Features and Diagnostic Pitfalls With Molecular Confirmation

    International Journal of Gynecological Pathology, 2026

    DOI 10.1097/pgp.0000000000001199 PMID 42312860 Açık erişimli tam metinKaynak: OpenAlex

  29. PAX8-Negative HPV-Associated Endocervical Adenocarcinoma With a Micropapillary Component: A Diagnostic Pitfall Mimicking Metastatic Carcinoma

    International Journal of Gynecological Pathology, 2026

    DOI 10.1097/pgp.0000000000001207 PMID 42460578 Kaynak: OpenAlex

  30. Novel Gene Fusions and Pathogenic CTNNB1 Mutation in Pilomatrix-like High-grade Endometrioid Carcinoma: Expanding the Molecular Spectrum

    International Journal of Gynecological Pathology, 2026

    DOI 10.1097/pgp.0000000000001212 PMID 42671904 Kaynak: OpenAlex

  31. Subcutaneous Adipose Tissue FDG Uptake is Associated with Systemic Inflammatory Indices Independent of Primary-Tumor Metabolic Burden in Breast Cancer

    Molecular Imaging and Biology, 2026

    DOI 10.1007/s11307-026-02138-0 PMID 42681307 Kaynak: OpenAlex

  32. Fibrolamellar Carcinoma in the Molecular Era: From DNAJB1::PRKACA Biology to Precision Therapeutic Strategies

    Journal of Gastrointestinal Cancer, 2026

    DOI 10.1007/s12029-026-01610-y PMID 42828719 Kaynak: OpenAlex

  33. Feasibility of androgen receptor pathway inhibitors in prostate cancer: impact of comorbidities, age, and concomitant medication use-a multicenter cohort study

    Journal of Health Sciences and Medicine, 2025

    DOI 10.32322/jhsm.1795533 Açık erişimli tam metinKaynak: ORCID

  34. Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer

    Journal of Cancer Research and Clinical Oncology, 2025

    DOI 10.1007/s00432-025-06336-1 PMID 41014426 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  35. Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice. Registurk-Lung National Registry Study

    BioRxiv, 2025

    Kaynak: ORCID

  36. Molecular profiling using NGS in lung cancer patients: Revolutionizing targeted therapy and personalized treatment

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e20654 Açık erişimli tam metinKaynak: ORCID

  37. The Role of [68Ga]Ga FAPi PET/CT in Staging and Restaging in Breast Cancer with Low FDG Uptake

    Research Square, 2025

    DOI 10.21203/rs.3.rs-6260191/v1 Açık erişimli tam metinKaynak: OpenAlex

  38. P2.10.02 Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice.Registurk-Lung National Registry Study

    Journal of Thoracic Oncology, 2025

    DOI 10.1016/j.jtho.2025.09.696 Açık erişimli tam metinKaynak: OpenAlex

  39. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552241241004 PMID 38613329 Açık erişimli tam metinKaynak: OpenAlex

  40. Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.96266 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  41. Assessment of the Clinicopathologic Characteristics and Survival Rates of Colorectal Cancer Among Syrian Refugees and Turkish Population in Gaziantep Province

    JCO Global Oncology, 2024

    DOI 10.1200/go.24.00211 PMID 39509657 Açık erişimli tam metinKaynak: OpenAlex

  42. Factors Affecting Perioperative Complications in Esophageal Cancer

    Bidge Yayınları eBooks, 2024

    DOI 10.70269/10.70269/8432622991 Kaynak: OpenAlex

  43. Current Approaches in Pulmonology and Thoracic Surgery

    Bidge Yayınları eBooks, 2024

    DOI 10.70269/oam9tvgs5j2e Açık erişimli tam metinKaynak: OpenAlex

  44. Surgery For Mediastinal Masses

    Bidge Yayınları eBooks, 2024

    DOI 10.70269/10.70269/9544364531 Kaynak: OpenAlex

  45. Göğüs Hastalıkları ve Göğüs Cerrahisinde Güncel Yaklaşımlar

    Bidge Yayınları eBooks, 2024

    DOI 10.70269/5m7xzt5lo7r4 Açık erişimli tam metinKaynak: OpenAlex

  46. Factors Affecting Perioperative Complications in Esophageal Cancer

    Bidge Yayınları eBooks, 2024

    DOI 10.70269/10.70269/1963381874 Kaynak: OpenAlex

  47. Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2022.08.016 PMID 36038467 1 atıf (Europe PMC) Kaynak: ORCID

  48. Where Should Enzalutamide Be in The Metastatic Castration Resistant Prostate Cancer (mCRPC): A Multi-center Study

    Eurasian Journal of Medicine and Oncology, 2023

    DOI 10.14744/ejmo.2023.69719 Açık erişimli tam metinKaynak: ORCID

  49. Psychological Impacts of COVID-19 Pandemic in Cancer Patients on Active Treatment

    2022

    DOI 10.2139/ssrn.4051677 Açık erişimli tam metinKaynak: ORCID

  50. Psychological impacts of COVID-19 pandemic in cancer patients on active treatment

    Heliyon, 2022

    DOI 10.1016/j.heliyon.2022.e10142 PMID 35996550 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID